Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 8;10(1):13.
doi: 10.1038/s41514-024-00136-6.

Cost of care for Alzheimer's disease and related dementias in the United States: 2016 to 2060

Arindam Nandi  1   2 , Nathaniel Counts  3 , Janina Bröker  4 , Sabrina Malik  5 , Simiao Chen  6 , Rachael Han  7 , Jessica Klusty  5 , Benjamin Seligman  8   9 , Daniel Tortorice  10 , Daniel Vigo  11 , David E Bloom  12
Affiliations

Cost of care for Alzheimer's disease and related dementias in the United States: 2016 to 2060

Arindam Nandi et al. NPJ Aging. .

Abstract

Medical and long-term care for Alzheimer's disease and related dementias (ADRDs) can impose a large economic burden on individuals and societies. We estimated the per capita cost of ADRDs care in the in the United States in 2016 and projected future aggregate care costs during 2020-2060. Based on a previously published methodology, we used U.S. Health and Retirement Survey (2010-2016) longitudinal data to estimate formal and informal care costs. In 2016, the estimated per patient cost of formal care was $28,078 (95% confidence interval [CI]: $25,893-$30,433), and informal care cost valued in terms of replacement cost and forgone wages was $36,667 ($34,025-$39,473) and $15,792 ($12,980-$18,713), respectively. Aggregate formal care cost and formal plus informal care cost using replacement cost and forgone wage methods were $196 billion (95% uncertainty range [UR]: $179-$213 billion), $450 billion ($424-$478 billion), and $305 billion ($278-$333 billion), respectively, in 2020. These were projected to increase to $1.4 trillion ($837 billion-$2.2 trillion), $3.3 trillion ($1.9-$5.1 trillion), and $2.2 trillion ($1.3-$3.5 trillion), respectively, in 2060.

PubMed Disclaimer

Conflict of interest statement

A.N., D.T., and D.E.B. consult for and J.K. is employed by Data for Decisions, LLC, whose clients include GSK, Merck, and Pfizer. These entities did not fund the research in this manuscript. B.S. has done pro bono advisory work for Ceresti Health, which did not fund the research in this manuscript. All other authors declare no conflict of interest. This publication does not represent the views of the Department of Veterans Affairs or the U.S. Government.

Figures

Fig. 1
Fig. 1
Projected cost of ADRDs formal and informal care in the United States, 2020 to 2060.
See this image and copyright information in PMC

References

    1. United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects. 2019. https://population.un.org/wpp/Publications/ (accessed April 6, 2022).
    1. Alzheimer’s Association. 2022 Alzheimer’s Disease Facts and Figures: 2022. https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf (accessed April 22, 2022).
    1. Rajan KB, et al. Population estimate of people with clinical Alzheimer’s disease and mild cognitive impairment in the United States (2020-2060) Alzheimers Dement. 2021;17:1966–1975. doi: 10.1002/alz.12362. - DOI - PMC - PubMed
    1. Tarawneh R, Holtzman DM. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harb. Perspect. Med. 2012;2:a006148. doi: 10.1101/cshperspect.a006148. - DOI - PMC - PubMed
    1. Deb A, Thornton JD, Sambamoorthi U, Innes K. Direct and indirect cost of managing alzheimer’s disease and related dementias in the United States. Expert. Rev. Pharmacoecon Outcomes Res. 2017;17:189–202. doi: 10.1080/14737167.2017.1313118. - DOI - PMC - PubMed